NCT00000233View on ClinicalTrials.gov

Alternate Day Buprenorphine Administration, Phase X - 15

PHASE2CompletedINTERVENTIONAL

0

Timeline

Start Date

May 31, 1993

Conditions

Opioid-Related Disorders

Interventions

DRUG

Buprenorphine

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors

collaborator

University of Vermont

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH